A new kind of vaccine is changing how people think about preventing breast cancer. Not just any breast cancer—this one ...

Anixa secures USPTO patent for its breast cancer vaccine using α-lactalbumin, enhancing its IP portfolio and expanding future ...

Toxic forever chemicals and nanoplastics can alter key proteins in human breast milk and cause developmental defects in children, two new studies have warned. Nanoplastics and polyfluoroalkyl ...

This is based on α-lactalbumin, a breast-specific differentiation antigen that is normally only expressed during lactation, but is present in the majority of human breast carcinomas. To test ...